Categories: ImplantsNews

Ortho Development Receives FDA Clearance on Trivicta Hip System

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

DRAPER, UT / ACCESSWIRE / March 14, 2024 / Ortho Development Corporation, a designer and manufacturer of orthopedic implants and instruments for hip and knee joint replacement surgery, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Trivicta™ Hip System. The triple-taper femoral stem facilitates an optimal fit within the canal for a diverse range of patient anatomies.

“Trivicta expands our extensive primary hip portfolio and incorporates our philosophy of evolutionary innovation. The system is designed to be versatile enough to address the vast needs of patients and surgeons, accommodating both muscle-sparing and traditional surgical approaches,” said Brent Bartholomew, President & CEO of Ortho Development.

Designed for initial and long-term stability, Trivicta boasts a triple-tapered geometry in three separate planes and incorporates two coatings. Sintered beads provide initial stability and allow ingrowth for long-term stability, while Hydroxyapatite promotes biological fixation. Additionally, extraction and compaction broaching are integrated in one broach to preserve bone while ensuring optimal fit.

Dr. Marc Hungerford, an orthopedic surgeon at Mercy Medical Center in Baltimore, MD, emphasized the benefits of the system: “The triple-taper stem geometry of Trivicta should result in a precise fit for most femoral morphologies. The unique advantage of this design is the ability to use extended offset to deliver direct lateralization independent of leg length.”

Trivicta will be available in the United States in the second quarter on a limited basis, with a full commercial release to follow.

About Ortho Development Corporation

Ortho Development Corporation designs, manufactures, and distributes orthopedic implants and related surgical instruments. The company’s principal product focus is total knee and hip joint replacement. To learn more visit: www.odev.com.

Contact: Phone: +1 801-553-9991 | Email: marketing@odev.com

Contact Information:

Dawn Boyd
Director of Marketing and Communications
dawn.boyd@orthodevelopment.com
512-508-5665

SOURCE: Ortho Development

View the original press release on newswire.com.

Staff

Recent Posts

Decisely Notifies Individuals of Data Security Incident

ALPHARETTA, Ga., June 13, 2025 /PRNewswire/ -- Decisely learned of a data security incident that may…

11 hours ago

Abstractive Health Launches Clinical Time Machine, the First AI Game Built on Real Historical Patient Records

NEW YORK--(BUSINESS WIRE)--#digitalhealth--Abstractive Health has launched Clinical Time Machine, an AI-driven simulation that immerses physicians…

17 hours ago

The Berwyn Group Appoints Adam Wilson as General Manager of Healthcare

Veteran Leader Brings Deep Industry Expertise to Advance Berwyn's Healthcare Strategy INDEPENDENCE, Ohio, June 13,…

17 hours ago

Datalogic and B. Braun enable safer oncology treatment with Memor™ 17 Healthcare Certification for OncoSafety Remote Control®

BOLOGNA, Italy, June 13, 2025 /PRNewswire/ -- Datalogic, a global leader in the automatic data capture…

17 hours ago

Skypoint Launches Lia and Scribe: AI-Powered Agents Redefining Clinical Workflow Efficiency and Social Determinants of Health (SDOH) Data Capture

PORTLAND, Ore., June 13, 2025 /PRNewswire/ -- Skypoint, a leading provider of HITRUST r2-certified AI platform…

23 hours ago

Prior to FIFA Club World Cup Kickoff, FC Mother and Omya Launch Landmark Joint Venture to Fund “Life Years” as Part of World Cup of Healing Legacy Project

First-of-its-kind joint venture funds longevity gains and maternal healing through football, creating a new category…

23 hours ago